- Recommendation ID
- NG242/3
- Question
What is the effectiveness and acceptability of observation, anti-vascular endothelial growth factor agents (anti-VEGFs) and laser photocoagulation (alone or in combination) for the treatment of severe non-proliferative diabetic retinopathy?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on treatment strategies for non-proliferative and proliferative diabetic retinopathy .
Full details of the evidence and the committee's discussion are in evidence review E: effectiveness and acceptability of anti-VEGFs and laser photocoagulation (alone or in combination) for the treatment of non-proliferative and proliferative diabetic retinopathy.
Source guidance details
- Comes from guidance
- Diabetic retinopathy: management and monitoring
- Number
- NG242
- Date issued
- August 2024
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 28/01/2025 |